A Longitudinal 3D Live-Cell Imaging Platform to Uncover AAV Vector–Host Dynamics at Single-Cell Resolution
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010236 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marlies Leysen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Trellis Research Group, Department of Cellular and Molecular Medicine, KU Leuven, B-3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Single-Cell Analysis, Imaging, Three-Dimensional. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Flanders Resilience subsidy, European Recovery and Resilience Facility, “Flanders Resilience” subsidy from the Flemish Government, originating from the “European Recovery and Resilience Facility”.
Abstract (Originalsprache)
Recombinant adeno-associated viral vectors (rAAVs) are the leading gene delivery vehicles in clinical development, yet efficient nuclear delivery remains a major barrier to effective transduction. This limitation is partly due to the incomplete understanding of rAAV’s complex subcellular trafficking dynamics. Here, we establish a longitudinal confocal live-cell imaging workflow that tracks rAAV2 from 4 to 12 h post-transduction, paired with an automated 3D analysis pipeline that quantifies spatiotemporal vector distribution, cytoplasmic trafficking, nuclear accumulation, and transgene expression at single-cell resolution. We use this platform to evaluate the effects of vector dose, cell cycle progression, and the behavior of empty particles. We identify previously undescribed trafficking features associated with high transgene expression. Higher rAAV2 doses enhanced cytoplasmic trafficking and nuclear delivery, while cell cycle progression facilitated both trafficking efficiency and transgene expression. We also characterize empty rAAV2 particles, revealing distinct trafficking patterns and markedly reduced nuclear accumulation compared to genome-containing vectors. By uncovering new bottlenecks in rAAV transduction, this platform provides mechanistic insights and potential strategies to improve AAV-based gene therapy. Its generalizable design further supports broad applicability to other non-enveloped viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Trellis Research Group, Department of Cellular and Molecular Medicine, KU Leuven, B-3000 Leuven, Belgium.
- VIB BioImaging Core Leuven, VIB Technologies, Center for Brain and Disease Research, B-3000 Leuven, Belgium.
- VIB BioImaging Core Leuven, Department of Neurosciences, KU Leuven, B-3000 Leuven, Belgium.
- VIB BioImaging Core Ghent, VIB Center for Inflammation Research, B-9052 Ghent, Belgium.
- Virus-Host Interactions & Therapeutic Approaches Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, B-3000 Leuven, Belgium.
ORCID-Profile: Nicolas Peredo
Förderung
- Flanders Resilience subsidy, European Recovery and Resilience Facility
- “Flanders Resilience” subsidy from the Flemish Government, originating from the “European Recovery and Resilience Facility”
Zitieren
APA
Leysen, M., Peredo, N., Pavie, B., Moeyaert, B., & Henckaerts, E. (2025). A Longitudinal 3D Live-Cell Imaging Platform to Uncover AAV Vector–Host Dynamics at Single-Cell Resolution. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010236
Vancouver
Leysen M, Peredo N, Pavie B, Moeyaert B, Henckaerts E. A Longitudinal 3D Live-Cell Imaging Platform to Uncover AAV Vector–Host Dynamics at Single-Cell Resolution. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010236
BibTeX
@article{Leysen2025,
author = {Leysen, Marlies and Peredo, Nicolas and Pavie, Benjamin and Moeyaert, Benjamien and Henckaerts, Els},
title = {A Longitudinal 3D Live-Cell Imaging Platform to Uncover AAV Vector–Host Dynamics at Single-Cell Resolution},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010236}
}
EUVIMED